Board of Directors

About

The board of directors at Amicus Therapeutics has a history of experience in the pharmaceutical industry and in venture capital. The current chairman was previously at Tempest Therapeutics, and the president and CEO was previously at Ardelyx, Inc. Another board member is a partner at New Enterprise Associates, and another was the senior vice president of therapeutics at Genzyme. All board members have experience in the pharmaceutical industry, with different focuses within the industry.

Team members

GS

Glenn P. Sblendorio

Director

LB

Lynn D. Bleil

Director

MM

Margaret G. Mcglynn

Director

MR

Michael G. Raab

Lead Independent Director

RE

Robert Essner

Director

Other teams at Amicus Therapeutics

View all

+6

Leadership Team

9 members

+5

CEO and Executive Team

8 members

Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.